seed
Stage
1
Investors
About
Pharmacelera develops proprietary computer-aided drug design software and provides computational chemistry services to pharmaceutical, biotech and research organizations. Their platform uses quantum‑mechanics algorithms, machine learning and high‑performance computing to explore ultra-large synthesizable chemical spaces for hit identification and lead optimization.
Explore Pharmacelera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.